KIMEE Maintains Accreditation for 26 Other Medical Schools

Deferred Non-Accreditation Lifted for Ulsan University, Wonkwang University, and Chungbuk National University

Konkuk University, Dongguk University, and Hallym University Colleges of Medicine have received a "deferred non-accreditation" verdict from the Korean Institute of Medical Education and Evaluation (KIMEE) in the medical education accreditation review.


Konkuk, Dongguk, and Hallym University Medical Schools Receive Deferred Non-Accreditation... Jeonbuk National Under Re-Evaluation View original image

On March 23, KIMEE released the results of the "2025 Second-Year Major Change Plan Review for Medical Education Accreditation." The review covered 30 medical schools and graduate schools of medicine nationwide, where the 2025 incoming student quota was significantly increased last year.


Of the universities evaluated, 26—excluding Konkuk University, Dongguk University, Hallym University, and Jeonbuk National University—received a "maintenance of accreditation" decision. Previously, the deferred non-accreditation status for Ulsan University, Wonkwang University, and Chungbuk National University, which had been issued in the first-year 2025 review, has been lifted.


KIMEE’s accreditation types are divided into accreditation and non-accreditation. Under deferred non-accreditation, the accreditation status is maintained for a one-year grace period; however, if a school receives a non-accreditation decision again in a subsequent review after one year, it faces disadvantages such as suspension of new student admissions.


The deferred non-accreditation period for Konkuk University, Dongguk University, and Hallym University runs from March 1, 2026, to February 28, 2027. Jeonbuk National University, meanwhile, has received a provisional deferred non-accreditation verdict and has requested a re-evaluation.


All medical schools nationwide must be accredited by KIMEE every two, four, or six years. In addition, a review is required whenever a major change that could significantly affect medical education occurs, such as "an increase of 10% or more in the admission quota."


Previously, KIMEE announced that the increase in medical school admissions for the 2025 academic year would bring complex changes that affect medical education annually from student recruitment to graduation, as well as infrastructure including faculty and facilities. As a result, KIMEE decided to conduct an annual major change review from the point the increase is decided until the graduation of the corresponding cohort—a total of six years—and carried out the first-year review in 2024.


The review found that a significant number of universities faced operational difficulties due to the so-called "doubling" situation, where they had to educate both the 2024 and 2025 student cohorts simultaneously, as a result of the increased 2025 admission quota and conflicts between the government and medical community. Many institutions, in particular, struggled to secure full-time faculty for both basic and clinical medical sciences.


However, as the 2026 admission quota is set to return to pre-increase levels, KIMEE explained that the major change review for the second year of 2025 has been streamlined by re-examining and adjusting the criteria for major change plan preparation and review targets, and by shortening the schedule for on-site evaluations.



KIMEE stated, "Following the Ministry of Education's announcement on March 13 regarding the allocation of medical student quotas, we are re-examining our evaluation plans, including the major change review for the 2026 (third-year) academic year, to ensure the quality and maintenance of medical education. We will continue to monitor and verify all necessary conditions—including the actual impact in educational settings, the adequacy of educational resources, and the requirements for maintaining the quality of medical education—comprehensively and on an ongoing basis."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing